Literature DB >> 34242730

The Role of the GABAergic System in Diseases of the Central Nervous System.

Wen Zhang1, Bing-Rui Xiong2, Long-Qing Zhang1, Xian Huang3, Xiaoman Yuan1, Yu-Ke Tian1, Xue-Bi Tian4.   

Abstract

It is well known that the central nervous system (CNS) is a complex neuronal network and its function depends on the balance between excitatory and inhibitory neurons. Disruption of the excitatory/inhibitory (E/I) balance is the main cause for the majority of the CNS diseases. In this review, we will discuss roles of the inhibitory system in the CNS diseases. The GABAergic system as the main inhibitory system, is essential for the appropriate functioning of the CNS, especially as it is engaged in the formation of learning and memory. Many researchers have reported that the GABAergic system is involved in regulating synaptic plasticity, cognition and long-term potentiation. Some clinical manifestations (such as cognitive dysfunctions, attention deficits, etc.) have also been shown to emerge after abnormalities in the GABAergic system accompanied with concomitant diseases, that include Alzheimer's disease (AD), Parkinson's disease (PD), Autism spectrum disorder (ASD), Schizophrenia, etc. The GABAergic system consists of GABA, GABA transporters, GABAergic receptors and GABAergic neurons. Changes in any of these components may contribute to the dysfunctions of the CNS. In this review, we will synthesize studies which demonstrate how the GABAergic system participates in the pathogenesis of the CNS disorders, which may provide a new idea that might be used to treat the CNS diseases.
Copyright © 2021 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  GABA; GABAergic receptors; GABAergic system; central nervous system; excitatory/inhibitory balance

Year:  2021        PMID: 34242730     DOI: 10.1016/j.neuroscience.2021.06.037

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  4 in total

Review 1.  Digging Deeper: Advancements in Visualization of Inhibitory Synapses in Neurodegenerative Disorders.

Authors:  Snježana Radulović; Sowmya Sunkara; Christa Maurer; Gerd Leitinger
Journal:  Int J Mol Sci       Date:  2021-11-18       Impact factor: 5.923

2.  Parvalbumin neuroplasticity compensates for somatostatin impairment, maintaining cognitive function in Alzheimer's disease.

Authors:  Christopher Daniel Morrone; Aaron Yenhsin Lai; Jossana Bishay; Mary Elizabeth Hill; JoAnne McLaurin
Journal:  Transl Neurodegener       Date:  2022-05-03       Impact factor: 9.883

3.  Overproduction of hydrogen sulfide, generated by cystathionine β-synthase, disrupts brain wave patterns and contributes to neurobehavioral dysfunction in a rat model of down syndrome.

Authors:  Theodora Panagaki; Laura Lozano-Montes; Lucia Janickova; Karim Zuhra; Marcell P Szabo; Tomas Majtan; Gregor Rainer; Damien Maréchal; Yann Herault; Csaba Szabo
Journal:  Redox Biol       Date:  2022-01-13       Impact factor: 10.787

Review 4.  Phenolics as GABAA Receptor Ligands: An Updated Review.

Authors:  José-Luis Ríos; Guillermo R Schinella; Inés Moragrega
Journal:  Molecules       Date:  2022-03-08       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.